This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Technoderma Medicines Pte Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Xiang Pan - Innovator in Small Molecule Compounds
Introduction
Xiang Pan is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of small molecule compounds. His work focuses on creating highly efficient and specific inhibitors for various kinases, which are crucial in the treatment of various diseases.
Latest Patents
Xiang Pan holds a patent for a small molecule compound characterized by its unique structural formula. This compound serves as a highly efficient and specific JAK kinase inhibitor, specifically targeting Tyk2 and JAK1, and functioning as a JAK1/Tyk2 dual inhibitor. His innovative approach in this area has the potential to lead to advancements in therapeutic options for patients.
Career Highlights
Xiang Pan is currently associated with Technoderma Medicines Pte Ltd., where he continues to push the boundaries of pharmaceutical research. His dedication to innovation in small molecule compounds has positioned him as a key figure in his field. With a patent portfolio that includes 1 patent, he exemplifies the spirit of invention and progress in medicinal chemistry.
Collaborations
Xiang Pan collaborates with Yuting Cai, working together to advance their research and development efforts in the pharmaceutical industry. Their partnership enhances the potential for groundbreaking discoveries in the field.
Conclusion
Xiang Pan's contributions to the development of small molecule compounds highlight his role as an influential inventor in the pharmaceutical industry. His work not only showcases his innovative spirit but also promises to impact the future of medicine significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile